Trials / Sponsors / Timmune Biotech Inc.
Timmune Biotech Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Treatment of Hematological Malignancy With Novel CAR-T Cells. B-cell Non Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma | EARLY_Phase 1 | 2019-09-01 |
| Unknown | Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy Non-Hodgkin Lymphoma of Intestine, Leukemia | EARLY_Phase 1 | 2019-03-21 |
| Unknown | Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy Non-Hodgkin Lymphoma | EARLY_Phase 1 | 2019-01-05 |
| Unknown | Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy Non-hodgkin Lymphoma,B Cell | Phase 1 | 2018-11-01 |
| Unknown | Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy Malignant Melanoma | EARLY_Phase 1 | 2018-09-27 |
| Unknown | Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 Non-hodgkin Lymphoma,B Cell | Phase 1 / Phase 2 | 2018-08-03 |